Meyka Pro banner
CanBas Co., Ltd.

CanBas Co., Ltd. Fundamental Analysis (JPX: 4575.T)

4575.TJPX
HealthcareBiotechnology
¥818.00
¥29.00(3.68%)
Japanese Market opens in 12h 51m

CanBas Co., Ltd. Fundamental Analysis (JPX: 4575.T)

CanBas Co., Ltd. (JPX: 4575.T) shows weak financial fundamentals with a PE ratio of -11.85, profit margin of 0.00%, and ROE of -60.26%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Current Ratio12.46

Areas of Concern

ROE-60.26%
Operating Margin0.00%
We analyze 4575.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -37.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-37.8/100

We analyze 4575.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

4575.T struggles to generate sufficient returns from assets.

ROA > 10%
-73.66%

Valuation Score

Excellent

4575.T trades at attractive valuation levels.

PE < 25
-11.85
PEG Ratio < 2
1.33

Growth Score

Weak

4575.T faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

4575.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
12.46

Profitability Score

Weak

4575.T struggles to sustain strong margins.

ROE > 15%
-6025.72%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is 4575.T Expensive or Cheap?

P/E Ratio

4575.T trades at -11.85 times earnings. This suggests potential undervaluation.

-11.85

PEG Ratio

When adjusting for growth, 4575.T's PEG of 1.33 indicates fair valuation.

1.33

Price to Book

The market values CanBas Co., Ltd. at 9.44 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

9.44

EV/EBITDA

Enterprise value stands at -12.59 times EBITDA. This is generally considered low.

-12.59

How Well Does 4575.T Make Money?

Net Profit Margin

For every $100 in sales, CanBas Co., Ltd. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-60.26 in profit for every $100 of shareholder equity.

-60.26%

ROA

CanBas Co., Ltd. generates $-73.66 in profit for every $100 in assets, demonstrating efficient asset deployment.

-73.66%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

4575.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.85

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.33

vs 25 benchmark

P/B Ratio

Price to book value ratio

9.44

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

12.46

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.60

vs 25 benchmark

ROA

Return on assets percentage

-0.74

vs 25 benchmark

ROCE

Return on capital employed

-0.83

vs 25 benchmark

How 4575.T Stacks Against Its Sector Peers

Metric4575.T ValueSector AveragePerformance
P/E Ratio-11.8532.14 Better (Cheaper)
ROE-60.26%550.00% Weak
Net Margin0.00%30133.00% Weak
Debt/Equity0.000.56 Strong (Low Leverage)
Current Ratio12.465.70 Strong Liquidity
ROA-73.66%3.00% Weak

4575.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CanBas Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ